Individual Patient Expanded Access to CA102N

ABSTRACT: This study is an individual patient expanded access protocol that the subject enrolled had completed the combination treatment of CA102N plus Lonsurf for at least 12 cycles.

DISEASE(S): Advanced Or Metastatic Colorectal Cancer (mcrc),Colorectal Neoplasms

PROVIDER: 2708903 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR